Healthcare
Proper labeling is an indispensable step when bringing cosmetics to the market. Within the scope of the article, we will provide detailed instructions on how to fully and accurately record each content on cosmetic labels according to current regulations and update some notable new points in the Draft Decree on cosmetic management in 2025 ("Draft Decree") to help businesses grasp changes and proactively adjust labels accordingly in accordance with regulations in the coming time.
In recent months, Vietnam's cosmetics industry has witnessed a series of cosmetic enterprises voluntarily revoking previously announced cosmetic product declaration forms. This shows that cosmetic businesses in Vietnam are reacting quickly to changes in the legal framework, strict management methods of competent authorities and changes in business strategies.
The Draft Decree regulating the management of cosmetics in Vietnam (Draft) is currently being developed with the goal of enhancing the efficiency of state management, protecting consumer rights and ensuring the quality of cosmetic products circulating on the market. The draft Decree is expected to create a transparent, synchronous and feasible legal corridor. However, through the process of consultation and research, we realized that many contents in the Draft still have inadequacies that need to be adjusted to suit international practices and practices. This article will analyze the points that need to be amended in the Draft Decree, and at the same time make specific recommendations to complete this document.
Import consignment is a popular method in the pharmaceutical industry in Vietnam, helping businesses optimize resources and take advantage of the expertise of entrusted units to import drugs. However, as in the case of the dispute between Vidipha Central Pharmaceutical Joint Stock Company (Vidipha), Nhat Duc Pharmaceutical Joint Stock Company (Nhat Duc), and E.U.R.O.L.I.N.K Pharmaceutical Joint Stock Company (Eurolink) in Judgment No. 105/2024/KDTM-PT dated May 7, 2024, the import entrustment may lead to serious legal disputes if not implemented in accordance with regulations fix.
The Law amending and supplementing a number of articles of the Law on Pharmacy (hereinafter referred to as the "Law on Pharmacy amended 2024") has supplemented regulations on the announcement of expected drug wholesale prices and the re-announcement of expected drug wholesale prices (hereinafter collectively referred to as 'price announcement'). This is a new procedure, completely different from the price declaration procedure specified in the Price Law 2023. The clear distinction between these two procedures is important in ensuring transparency, avoiding legal overlap and enhancing the efficiency of state management of the pharmaceutical market.
The Law on Pharmacy 2024 is considered to have helped expand the ability to develop the pharmacy chain model as a step forward in modernizing the pharmaceutical distribution system. But the burden of administrative procedures has not been eased much. The overlap in registration procedures not only reduces the efficiency of centralized management and hinders the modernization of the supply chain to bring pharmaceuticals to consumers.
The global pharmaceutical industry is entering a period of strong transformation. Geopolitical upheavals, rapid technological advancements, and increasing regulatory pressures have been reshaping the way the pharmaceutical industry operates, with many innovations and expansions of its scope and impact on human life. Latham & Watkins' "Healthcare & Life Sciences Market Update" report, one of the world's leading law firms, recently pointed to key global strategic trends. Notably, many of these trends have been creating obvious spillover effects on Vietnam – a pharmaceutical market that is on the verge of strong development in Southeast Asia.
The drug introduction seminar is one of the forms of drug information recorded in the law on pharmacy. This is a drug introduction or topical discussion related to drugs for medical and pharmaceutical practitioners . In particular, the certificate of drug information content is one of the important conditions for organizing drug introduction seminars.
The food supply chain comprises three key stakeholders: suppliers, distributors, and certification authorities. Thus, when FSH incidents occur, what are the roles and responsibilities of these stakeholders? Who bears the highest level of accountability, and to what extent?
At the 8th Session of the 15th Assembly, the National Assembly passed the Law amending and supplementing a number of articles of the Law on Pharmacy ("Amended Law on Pharmacy"). This is a necessary adjustment after nearly 8 years of implementation of the 2016 Law on Pharmacy - the legal framework governing the production, trade, distribution and use of medicines in Vietnam. In the context of deep international integration and the focus on developing the pharmaceutical industry into a key economic sector, the amended Law on Pharmacy is expected to improve management efficiency and attract investment. However, many of the new regulations are not yet complete, which poses certain challenges in achieving the long-term goals set. This article will focus on the remaining limitations that the Amended Pharmacy Law has not yet resolved, which could pose obstacles to the implementation of the newly adopted reforms.
After nearly eight years of implementation, the Law on Pharmacy 2016 has proven to be an important legal tool for regulating the production, business, distribution, and use of pharmaceuticals in Vietnam. However, in the context of international integration and the development of Vietnam's pharmaceutical industry into a key sector, amending the Law on Pharmacy to support pharmaceutical enterprises and improve efficiency and transparency is an inevitable step. Based on this, the following article will analyze the impact of several provisions in the Amended Law on Pharmacy on domestic pharmaceutical enterprises and foreign-invested pharmaceutical enterprises.
Veterinary medicine wholesale is a conditional business. When doing business in this industry, both domestic and foreign-invested enterprises are required to apply for a license to conduct veterinary medicine wholesale business.
-
-